Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease

Autor(en): Förster, S.
Buschert, V.C.
Teipel, S.J.
Friese, U. 
Buchholz, H.-G.
Drzezga, A.
Hampel, H.
Bartenstein, P.
Buerger, K.
Herausgeber: Wesson Ashford, J.
Rosen, A.
Adamson, M.
Bayley, P.
Furst, A.
Sabri, O.
Black, S.E.
Weiner, M.
Stichwörter: fluorodeoxyglucose f 18, 63503-12-8; aged; Alzheimer disease; Alzheimer Disease Assessment Scale cognitive subscale; Alzheimer's disease; article; association cortex; brain mapping; brain metabolism; clinical article; clinical effectiveness; cognitive intervention; cognitive stimulation; cognitive training; conservative treatment; controlled study; drug uptake; energy metabolism; exercise; FDG PET; female; fluorodeoxyglucose f 18, adult; human; image analysis; image quality; intervention study; male; mild cognitive impairment; mini mental state examination; Montgomery Asberg Depression Rating Scale; multicenter study; neuroimaging; neuropsychological test; outcome assessment; pencil paper exercise; positron emission tomography; posterior cingulate; precuneus; prefrontal cortex; randomized controlled trial; scoring system; temporal cortex; temporooccipital association cortex
Erscheinungsdatum: 2011
Enthalten in: Advances in Alzheimer's Disease
Band: 2
Startseite: 605
Seitenende: 616
Zusammenfassung: 
The effect of cognitive intervention on brain metabolism in AD is largely unexplored. Therefore, we aimed to investigate cognitive parameters and 18FDG PET to test for effects of a cognitive intervention in patients with aMCI or mild AD. Patients with aMCI (N = 24) or mild AD (N = 15) were randomly assigned either to cognitive intervention groups (IGs), receiving weekly sessions of group-based multicomponent cognitive intervention, or active control groups (CGs), receiving pencil-paper exercises for self-study. We obtained resting-state FDG-PET scans and neuropsychological testing at baseline and after six-months. Normalized FDG-PET images were analyzed using voxel-based SPM5 approaches to determine longitudinal changes, group-by-time interactions and correlations with neuropsychological outcome parameters. Primary global cognitive outcome was determined by analyses of covariance with MMSE and ADAS-cog scores as dependent measures. Both, aMCI and AD subgroups of CGs showed widespread bilateral cortical declines in FDG uptake, while the AD subgroup of IGs showed discrete decline or rather no decline in case of the aMCI subgroup. Group by time analyses revealed strongest attenuation of metabolic decline in the aMCI subgroup of the IGs, involving left anterior temporal pole and anterior cingulate gyrus. However, correlation analyses revealed only weak non-significant associations between increased FDG uptake and improvement in primary or secondary outcome parameters. Concurrently, there was significant improvement in global cognitive status in the aMCI subgroup of the IGs. A six-month cognitive intervention imparted cognitive benefits in patients with aMCI, which were concurrent with an attenuated decline of glucose metabolism in cortical regions affected by neurodegenerative AD. © 2011 The authors and IOS Press. All rights reserved.
ISBN: 9781607507925
ISSN: 22105727
DOI: 10.3233/978-1-60750-793-2-605
Externe URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865417420&doi=10.3233%2f978-1-60750-793-2-605&partnerID=40&md5=eadf2736fb84a13cc35f3d1fbe267614

Zur Langanzeige

Seitenaufrufe

6
Letzte Woche
0
Letzter Monat
0
geprüft am 07.06.2024

Google ScholarTM

Prüfen

Altmetric